OPCH Quote, Financials, Valuation and Earnings

Amedisys has a net margin of 4.47% compared to Option Care Health's net margin of -3.41%. Option Care Health's return on equity of 14.93% beat Amedisys's return on equity of 3.71%.

Option Care Health has a consensus price target of $37.78, signalling upside risk potential of 15.18%. On the other hand Amedisys has an analysts' consensus of $97.38 which suggests that it could grow by 6.64%. Given that Option Care Health has higher upside potential than Amedisys, analysts believe Option Care Health is more attractive than Amedisys.

Option Care Health has a beta of 1.074, which suggesting that the stock is 7.353% more volatile than S&P 500. In comparison Amedisys has a beta of 0.890, suggesting its less volatile than the S&P 500 by 11.035%.

Option Care Health has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Amedisys offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Option Care Health pays -- of its earnings as a dividend. Amedisys pays out -- of its earnings as a dividend.

Option Care Health quarterly revenues are $1.3B, which are larger than Amedisys quarterly revenues of $598.1M. Option Care Health's net income of $60.1M is higher than Amedisys's net income of -$20.4M. Notably, Option Care Health's price-to-earnings ratio is 26.89x while Amedisys's PE ratio is 69.70x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Option Care Health is 1.13x versus 1.29x for Amedisys. Usually stocks with elevated PS ratios are considered overvalued.

AMN Healthcare Services has a net margin of 4.47% compared to Option Care Health's net margin of -25.53%. Option Care Health's return on equity of 14.93% beat AMN Healthcare Services's return on equity of -17.67%.

Option Care Health has a consensus price target of $37.78, signalling upside risk potential of 15.18%. On the other hand AMN Healthcare Services has an analysts' consensus of $39.50 which suggests that it could grow by 102.88%. Given that AMN Healthcare Services has higher upside potential than Option Care Health, analysts believe AMN Healthcare Services is more attractive than Option Care Health.

Option Care Health has a beta of 1.074, which suggesting that the stock is 7.353% more volatile than S&P 500. In comparison AMN Healthcare Services has a beta of -0.025, suggesting its less volatile than the S&P 500 by 102.532%.

Option Care Health has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. AMN Healthcare Services offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Option Care Health pays -- of its earnings as a dividend. AMN Healthcare Services pays out -- of its earnings as a dividend.

Option Care Health quarterly revenues are $1.3B, which are larger than AMN Healthcare Services quarterly revenues of $734.7M. Option Care Health's net income of $60.1M is higher than AMN Healthcare Services's net income of -$187.5M. Notably, Option Care Health's price-to-earnings ratio is 26.89x while AMN Healthcare Services's PE ratio is 18.72x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Option Care Health is 1.13x versus 0.25x for AMN Healthcare Services. Usually stocks with elevated PS ratios are considered overvalued.

Chemed has a net margin of 4.47% compared to Option Care Health's net margin of 14.11%. Option Care Health's return on equity of 14.93% beat Chemed's return on equity of 25.8%.

Option Care Health has a consensus price target of $37.78, signalling upside risk potential of 15.18%. On the other hand Chemed has an analysts' consensus of $675.00 which suggests that it could grow by 18.06%. Given that Chemed has higher upside potential than Option Care Health, analysts believe Chemed is more attractive than Option Care Health.

Option Care Health has a beta of 1.074, which suggesting that the stock is 7.353% more volatile than S&P 500. In comparison Chemed has a beta of 0.494, suggesting its less volatile than the S&P 500 by 50.626%.

Option Care Health has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Chemed offers a yield of 0.33% to investors and pays a quarterly dividend of $0.50 per share. Option Care Health pays -- of its earnings as a dividend. Chemed pays out 8.97% of its earnings as a dividend. Chemed's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Option Care Health quarterly revenues are $1.3B, which are larger than Chemed quarterly revenues of $640M. Option Care Health's net income of $60.1M is lower than Chemed's net income of $90.3M. Notably, Option Care Health's price-to-earnings ratio is 26.89x while Chemed's PE ratio is 28.72x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Option Care Health is 1.13x versus 3.57x for Chemed. Usually stocks with elevated PS ratios are considered overvalued.

OptimizeRx has a net margin of 4.47% compared to Option Care Health's net margin of -0.24%. Option Care Health's return on equity of 14.93% beat OptimizeRx's return on equity of -16.71%.

Option Care Health has a consensus price target of $37.78, signalling upside risk potential of 15.18%. On the other hand OptimizeRx has an analysts' consensus of $10.33 which suggests that it could grow by 38.89%. Given that OptimizeRx has higher upside potential than Option Care Health, analysts believe OptimizeRx is more attractive than Option Care Health.

Option Care Health has a beta of 1.074, which suggesting that the stock is 7.353% more volatile than S&P 500. In comparison OptimizeRx has a beta of 1.179, suggesting its more volatile than the S&P 500 by 17.909%.

Option Care Health has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. OptimizeRx offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Option Care Health pays -- of its earnings as a dividend. OptimizeRx pays out -- of its earnings as a dividend.

Option Care Health quarterly revenues are $1.3B, which are larger than OptimizeRx quarterly revenues of $32.3M. Option Care Health's net income of $60.1M is higher than OptimizeRx's net income of -$78K. Notably, Option Care Health's price-to-earnings ratio is 26.89x while OptimizeRx's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Option Care Health is 1.13x versus 1.48x for OptimizeRx. Usually stocks with elevated PS ratios are considered overvalued.